Abstract 950: In vivo efficacy and pharmacodynamic modulation of JNJ-64619178, a selective PRMT5 inhibitor, in human lung and hematologic preclinical models

MLA

Tinne Verhulst, et al. “Abstract 950: In Vivo Efficacy and Pharmacodynamic Modulation of JNJ-64619178, a Selective PRMT5 Inhibitor, in Human Lung and Hematologic Preclinical Models.” Cancer Research, vol. 79, July 2019, p. 950. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........1b3d4ec4e7e41833e3a1b01ba499f744&authtype=sso&custid=ns315887.

APA

Tinne Verhulst, Tongfei Wu, An Boeckx, Nahor Haddish-Berhane, Erika van Heerde, Joseph Portale, Dirk Brehmer, Tony Greway, Kathryn Packman, Hillary Millar, Dana Gaffney, Sylvie Laquerre, Thomas Nys, & Ulrike Philippar. (2019). Abstract 950: In vivo efficacy and pharmacodynamic modulation of JNJ-64619178, a selective PRMT5 inhibitor, in human lung and hematologic preclinical models. Cancer Research, 79, 950.

Chicago

Tinne Verhulst, Tongfei Wu, An Boeckx, Nahor Haddish-Berhane, Erika van Heerde, Joseph Portale, Dirk Brehmer, et al. 2019. “Abstract 950: In Vivo Efficacy and Pharmacodynamic Modulation of JNJ-64619178, a Selective PRMT5 Inhibitor, in Human Lung and Hematologic Preclinical Models.” Cancer Research 79 (July): 950. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........1b3d4ec4e7e41833e3a1b01ba499f744&authtype=sso&custid=ns315887.